Evidence map›Paper›PMID 42321221›Full record

ArticleNature communications2026

Engineered halohydrin dehalogenase mediates remote enantiocontrolled dehalogenative hydroxylation via an unconventional mechanism.

Xiao Jin, Hai-Xia Zhang, Kui-De Lu, Zhang-Yang Wang, Hui-Hui Wang, Yong-Zheng Chen, Nan-Wei Wan

Abstract read
In one paragraph

Article in Nature communications, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Xiao Jin *School of Pharmacy, Zunyi Medical University, Zunyi, China.
Hai-Xia Zhang *School of Pharmacy, Zunyi Medical University, Zunyi, China.
Kui-De LuSchool of Pharmacy, Zunyi Medical University, Zunyi, China.
Zhang-Yang WangSchool of Pharmacy, Zunyi Medical University, Zunyi, China.
Hui-Hui WangSchool of Pharmacy, Zunyi Medical University, Zunyi, China.
Yong-Zheng ChenSchool of Pharmacy, Zunyi Medical University, Zunyi, China.ORCID http://orcid.org/0000-0003-1211-3486
Nan-Wei WanSchool of Pharmacy, Zunyi Medical University, Zunyi, China. nanweiwan@zmu.edu.cn.ORCID http://orcid.org/0000-0003-3561-8380

Funding

National Natural Science Foundation of China (National Science Foundation of China) 22577170National Natural Science Foundation of China (National Science Foundation of China) 32401047
6 · The paper itself

Abstract

Expanding enzyme catalytic diversity is essential to unlocking the full potential of biocatalysis for green chemistry. Halohydrin dehalogenases are promiscuous biocatalysts that typically mediate the intramolecular dehalogenative cyclization of haloalcohols to form cyclic ethers, as well as the ring-opening of these O-heterocycles with various anionic nucleophiles. Here we report that engineered variants of the halohydrin dehalogenase HheC instead catalyze an intermolecular dehalogenative hydroxylation of ε-haloalcohols with remote enantiocontrol. Mechanistic investigations establish that an Asp-Arg dyad serves as the key catalytic motif responsible for this unconventional dehalogenation pathway. Through directed evolution, we further improve both the remote stereoselectivity and catalytic efficiency of the enzyme and systematically profile its substrate scope. The biocatalytic process is also successfully scaled to preparative and gram scales for the synthesis of chiral ε-haloalcohols and ε-diols. Our work uncovers an unusual dehalogenation mechanism and a practical platform for enantiocontrolled synthesis of chiral ε-substituted alcohols.

Indexed as

Bacterial ProteinsHydrolasesAlcoholsBiocatalysisDirected Molecular EvolutionHalogenationHydroxylationProtein EngineeringStereoisomerismSubstrate SpecificityAlcoholsBacterial Proteinshalohydrin dehalogenaseHydrolases

Identifiers

PMID42321221
PMCPMC13434774

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.